Description
Description
Glem-Lin MXR 12.5/2.5/1000mg is a specially balanced triple-combination prescription medicine manufactured by NABIQASIM Industries, formulated with Empagliflozin 12.5mg, Linagliptin 2.5mg, and Metformin 1000mg. This extended-release tablet is designed for patients who require a customized dosing balance between the two lower- and higher-strength formulations. It combines three complementary mechanisms of action: Empagliflozin, which supports glucose elimination through the kidneys; Linagliptin, which enhances natural insulin secretion while reducing excess glucose production; and Metformin, a well-established therapy that improves insulin sensitivity and lowers hepatic glucose output. This tailored combination helps physicians fine-tune treatment for patients with type 2 diabetes based on their individual response and tolerance.
Ingredients
Each extended-release tablet contains Empagliflozin 12.5mg, Linagliptin 2.5mg, and Metformin Hydrochloride 1000mg, along with pharmaceutical-grade excipients that support controlled drug release, tablet stability, and consistent absorption.
Dosage Form
Glem-Lin MXR 12.5/2.5/1000mg is available as an oral extended-release film-coated tablet, supplied in a strip of 14 tablets for structured daily therapy.
Uses
Glem-Lin MXR 12.5/2.5/1000mg is prescribed to:
- Provide customized, intermediate-strength blood glucose control in adults with type 2 diabetes mellitus
- Offer balanced triple-mechanism therapy for patients requiring dose adjustment between available strengths
- Support ongoing glycemic management alongside diet and physical activity
- Simplify treatment by combining three glucose-lowering agents into a single daily tablet
Your physician will determine suitability based on kidney function, liver health, and your response to previous diabetes therapy.
How To Use
Take Glem-Lin MXR exactly as prescribed by your doctor, typically once daily with a meal to help reduce gastrointestinal discomfort associated with Metformin. Swallow the tablet whole with water; avoid crushing, splitting, or chewing it, as doing so may interfere with its extended-release action. Maintain consistent timing each day and follow your prescribed dietary and lifestyle recommendations. Do not change your dose or stop treatment without consulting your doctor first.
Side Effects
Common side effects may include gastrointestinal discomfort such as nausea, diarrhea, or stomach upset, especially during the early stages of Metformin therapy. Empagliflozin may contribute to urinary tract infections, genital yeast infections, or increased urination, while Linagliptin may cause mild headache or nasopharyngitis. Less commonly, long-term Metformin use may lead to vitamin B12 deficiency, and the combination may increase the risk of dehydration or low blood sugar when used with other diabetes medicines. Seek urgent medical attention if you notice signs of lactic acidosis, such as severe muscle pain, breathing difficulty, or unusual fatigue.
Pregnancy & Breastfeeding
Glem-Lin MXR is generally not recommended during pregnancy due to limited safety data on this specific combination, with physicians typically preferring alternative treatments during this period. It remains unclear whether all components pass into breast milk, so breastfeeding mothers should consult their doctor before starting this medicine.
Storage Instructions
Store Glem-Lin MXR tablets in a cool, dry place away from direct sunlight and moisture, at a temperature below 30°C. Keep tablets in their original blister packaging and store out of reach of children.
FAQs
Q: Why does this strength exist between the other two formulations?
A: This intermediate dose allows doctors to fine-tune treatment for patients who need a level of control between the lower and higher strengths.
Q: Can I switch to this strength from another Glem-Lin MXR dose?
A: Any dose transition should only be made under your doctor’s supervision based on your blood sugar response.
Q: Should this tablet always be taken with food?
A: Yes, taking it with meals helps minimize digestive side effects commonly associated with Metformin.
Q: What tests are recommended during treatment?
A: Doctors typically monitor kidney function, vitamin B12 levels, and blood glucose periodically for safe, effective use.
Disclaimer
Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.






Reviews
There are no reviews yet.